Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

The oncoprotein HBXIP upregulates PDGFB via activating transcription factor Sp1 to promote the proliferation of breast cancer cells.

Zhang Y, Zhao Y, Li L, Shen Y, Cai X, Zhang X, Ye L.

Biochem Biophys Res Commun. 2013 May 3;434(2):305-10. doi: 10.1016/j.bbrc.2013.02.123. Epub 2013 Mar 26.

PMID:
23537647
2.

The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells.

Yue L, Li L, Liu F, Hu N, Zhang W, Bai X, Li Y, Zhang Y, Fu L, Zhang X, Ye L.

Carcinogenesis. 2013 Apr;34(4):927-35. doi: 10.1093/carcin/bgs399. Epub 2013 Jan 5.

3.

The oncoprotein HBXIP up-regulates FGF4 through activating transcriptional factor Sp1 to promote the migration of breast cancer cells.

Shi H, Li Y, Feng G, Li L, Fang R, Wang Z, Qu J, Ding P, Zhang X, Ye L.

Biochem Biophys Res Commun. 2016 Feb 26;471(1):89-94. doi: 10.1016/j.bbrc.2016.01.174. Epub 2016 Jan 29.

PMID:
26828265
4.

The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1.

Xu F, Zhu X, Han T, You X, Liu F, Ye L, Zhang X, Wang X, Yao Y.

Int J Oncol. 2014 Jul;45(1):255-63. doi: 10.3892/ijo.2014.2411. Epub 2014 Apr 29.

PMID:
24788380
5.

The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.

Liu S, Li L, Zhang Y, Zhang Y, Zhao Y, You X, Lin Z, Zhang X, Ye L.

J Biol Chem. 2012 Aug 31;287(36):30228-39. doi: 10.1074/jbc.M112.343947. Epub 2012 Jun 27.

6.

The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF.

Liu F, You X, Wang Y, Liu Q, Liu Y, Zhang S, Chen L, Zhang X, Ye L.

Carcinogenesis. 2014 May;35(5):1144-53. doi: 10.1093/carcin/bgu021. Epub 2014 Jan 24.

7.

The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells.

Xu F, You X, Liu F, Shen X, Yao Y, Ye L, Zhang X.

Cancer Lett. 2013 Jun 1;333(1):124-32. doi: 10.1016/j.canlet.2013.01.029. Epub 2013 Jan 22.

PMID:
23352642
8.

The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells.

Liu Q, Bai X, Li H, Zhang Y, Zhao Y, Zhang X, Ye L.

Int J Cancer. 2013 Sep 15;133(6):1310-22. doi: 10.1002/ijc.28154. Epub 2013 Apr 5.

9.

miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8.

Hu N, Zhang J, Cui W, Kong G, Zhang S, Yue L, Bai X, Zhang Z, Zhang W, Zhang X, Ye L.

J Biol Chem. 2011 Apr 15;286(15):13714-22. doi: 10.1074/jbc.M110.204131. Epub 2011 Feb 22.

10.

Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.

Zhang W, Lu Z, Kong G, Gao Y, Wang T, Wang Q, Cai N, Wang H, Liu F, Ye L, Zhang X.

Mol Cancer. 2014 May 28;13:128. doi: 10.1186/1476-4598-13-128.

11.

The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.

Li H, Liu Q, Wang Z, Fang R, Shen Y, Cai X, Gao Y, Li Y, Zhang X, Ye L.

J Biol Chem. 2015 Sep 11;290(37):22649-61. doi: 10.1074/jbc.M115.658468. Epub 2015 Jul 30.

PMID:
26229107
12.

The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling.

Li Y, Zhang Z, Zhou X, Li L, Liu Q, Wang Z, Bai X, Zhao Y, Shi H, Zhang X, Ye L.

Cancer Lett. 2014 Dec 28;355(2):288-96. doi: 10.1016/j.canlet.2014.09.047. Epub 2014 Oct 7.

PMID:
25304384
13.

The nuclear import of oncoprotein hepatitis B X-interacting protein depends on interacting with c-Fos and phosphorylation of both proteins in breast cancer cells.

Zhang Y, Zhao Y, Li H, Li Y, Cai X, Shen Y, Shi H, Li L, Liu Q, Zhang X, Ye L.

J Biol Chem. 2013 Jun 28;288(26):18961-74. doi: 10.1074/jbc.M113.458638. Epub 2013 May 10.

14.
15.

The oncoprotein HBXIP promotes migration of breast cancer cells via GCN5-mediated microtubule acetylation.

Li L, Liu B, Zhang X, Ye L.

Biochem Biophys Res Commun. 2015 Mar 13;458(3):720-5. doi: 10.1016/j.bbrc.2015.02.036. Epub 2015 Feb 14.

PMID:
25686500
16.

The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells.

Wang Y, Cui M, Cai X, Sun B, Liu F, Zhang X, Ye L.

Cancer Lett. 2014 Oct 1;352(2):169-78. doi: 10.1016/j.canlet.2014.05.007. Epub 2014 May 29.

PMID:
24882622
17.

Insulin-dependent leptin expression in breast cancer cells.

Bartella V, Cascio S, Fiorio E, Auriemma A, Russo A, Surmacz E.

Cancer Res. 2008 Jun 15;68(12):4919-27. doi: 10.1158/0008-5472.CAN-08-0642.

18.

Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.

Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, Freeman JW.

J Biol Chem. 2005 Mar 18;280(11):10047-54. Epub 2005 Jan 12.

19.

The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.

Liu F, Zhang W, You X, Liu Y, Li Y, Wang Z, Wang Y, Zhang X, Ye L.

Oncotarget. 2015 Sep 29;6(29):27199-213. doi: 10.18632/oncotarget.4508.

20.

Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.

Yan Y, Dalmasso G, Sitaraman S, Merlin D.

Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G535-45. Epub 2006 Oct 5.

Items per page

Supplemental Content

Write to the Help Desk